Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$965K Sell
3,199
-5,361
-63% -$1.06M 0.02% 416
2026
Q1
$1.26M Sell
8,560
-8,220
-49% -$1.2M 0.03% 326
2025
Q4
$2.04M Sell
16,780
-5,390
-24% -$632K 0.04% 194
2025
Q3
$2.39M Sell
22,170
-6,590
-23% -$615K 0.06% 163
2025
Q2
$2.58M Buy
28,760
+17,900
+165% +$1.35M 0.07% 149
2025
Q1
$738K Buy
+10,860
New +$782K 0.03% 385

Other funds holding KLAC

Caxton Associates (UK)'s KLAC Position: Q2 2026 in Review

Caxton Associates (UK) reduced its KLA (KLAC) stake by 63% in Q2 2026, selling an estimated $1.06M and leaving 3,199 shares worth $965K. The position accounts for 0.02% of the portfolio, ranked #416.

Caxton Associates (UK) first reported a position in KLAC in Q1 2025 and has held it in 6 quarters since. The position peaked at $2.58M in Q2 2025. 2,485 funds tracked by Wall St. Rank hold KLAC as of Q2 2026.

  • Caxton Associates (UK) held 3,199 shares of KLA worth $965K as of Q2 2026.
  • Caxton Associates (UK) sold 5,361 KLA shares in Q2 2026, an estimated $1.06M.
  • KLA made up 0.02% of Caxton Associates (UK)'s portfolio in Q2 2026, its #416 holding.
  • Caxton Associates (UK) first reported a position in KLA in Q1 2025 and has held it in 6 quarters since.
  • Caxton Associates (UK)'s KLA position peaked at $2.58M in Q2 2025.
  • 2,485 funds tracked by Wall St. Rank held KLA as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.